

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lateral sprouting from an epithelium (GO:0060601) | 7.41828923 |
| 2 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 6.52320539 |
| 3 | regulation of mononuclear cell migration (GO:0071675) | 5.75997981 |
| 4 | cell proliferation involved in metanephros development (GO:0072203) | 5.52519999 |
| 5 | cell proliferation involved in kidney development (GO:0072111) | 5.35150044 |
| 6 | glycosphingolipid catabolic process (GO:0046479) | 5.33684581 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 5.32187684 |
| 8 | response to peptidoglycan (GO:0032494) | 5.04913878 |
| 9 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.99059901 |
| 10 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.96702626 |
| 11 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.90399257 |
| 12 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.90021172 |
| 13 | positive regulation of heat generation (GO:0031652) | 4.88501158 |
| 14 | glycolipid catabolic process (GO:0019377) | 4.75248111 |
| 15 | mesenchymal cell proliferation (GO:0010463) | 4.67274721 |
| 16 | oligosaccharide catabolic process (GO:0009313) | 4.60784250 |
| 17 | regulation of fever generation (GO:0031620) | 4.57865918 |
| 18 | bone trabecula formation (GO:0060346) | 4.56709220 |
| 19 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 4.54240067 |
| 20 | amino sugar catabolic process (GO:0046348) | 4.48090928 |
| 21 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.48059583 |
| 22 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 4.42031955 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.33449039 |
| 24 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.32242788 |
| 25 | radial glial cell differentiation (GO:0060019) | 4.31446479 |
| 26 | ceramide catabolic process (GO:0046514) | 4.21806787 |
| 27 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.21606734 |
| 28 | branching involved in salivary gland morphogenesis (GO:0060445) | 4.17924375 |
| 29 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.16436002 |
| 30 | T-helper 1 type immune response (GO:0042088) | 4.15679999 |
| 31 | response to thyroid hormone (GO:0097066) | 4.14261925 |
| 32 | regulation of podosome assembly (GO:0071801) | 4.12369989 |
| 33 | regulation of chemokine biosynthetic process (GO:0045073) | 4.11567468 |
| 34 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 4.10937134 |
| 35 | convergent extension (GO:0060026) | 4.10310429 |
| 36 | craniofacial suture morphogenesis (GO:0097094) | 4.01905939 |
| 37 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.99823287 |
| 38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.94311674 |
| 39 | macrophage differentiation (GO:0030225) | 3.87458491 |
| 40 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.84129515 |
| 41 | positive regulation of p38MAPK cascade (GO:1900745) | 3.79517440 |
| 42 | monocyte chemotaxis (GO:0002548) | 3.77726181 |
| 43 | negative regulation of catenin import into nucleus (GO:0035414) | 3.77561071 |
| 44 | membrane lipid catabolic process (GO:0046466) | 3.76638750 |
| 45 | regulation of heat generation (GO:0031650) | 3.76480245 |
| 46 | regulation of vitamin metabolic process (GO:0030656) | 3.75271566 |
| 47 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.72969053 |
| 48 | adhesion of symbiont to host cell (GO:0044650) | 3.69189147 |
| 49 | virion attachment to host cell (GO:0019062) | 3.69189147 |
| 50 | mesenchyme morphogenesis (GO:0072132) | 3.68027644 |
| 51 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.63254256 |
| 52 | mesonephros development (GO:0001823) | 3.62834219 |
| 53 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.61082301 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 3.59387368 |
| 55 | N-acetylneuraminate metabolic process (GO:0006054) | 3.57593126 |
| 56 | polarized epithelial cell differentiation (GO:0030859) | 3.57384735 |
| 57 | sphingolipid catabolic process (GO:0030149) | 3.55593788 |
| 58 | mesenchymal cell differentiation (GO:0048762) | 3.54907045 |
| 59 | renal system development (GO:0072001) | 3.54774994 |
| 60 | establishment of apical/basal cell polarity (GO:0035089) | 3.53897685 |
| 61 | regulation of macrophage chemotaxis (GO:0010758) | 3.52066817 |
| 62 | axis elongation (GO:0003401) | 3.43122688 |
| 63 | hindlimb morphogenesis (GO:0035137) | 3.41982034 |
| 64 | endocardial cushion morphogenesis (GO:0003203) | 3.41256393 |
| 65 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.40530649 |
| 66 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.38382128 |
| 67 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 3.37602398 |
| 68 | paraxial mesoderm development (GO:0048339) | 3.36967389 |
| 69 | sphingosine metabolic process (GO:0006670) | 3.36660245 |
| 70 | negative regulation of cartilage development (GO:0061037) | 3.35925497 |
| 71 | keratinocyte proliferation (GO:0043616) | 3.32884761 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 3.30737041 |
| 73 | outer ear morphogenesis (GO:0042473) | 3.30682882 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.29572581 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 3.29572581 |
| 76 | regulation of chronic inflammatory response (GO:0002676) | 3.29111858 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 3.28492275 |
| 78 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.28307752 |
| 79 | positive regulation of leukocyte degranulation (GO:0043302) | 3.27128012 |
| 80 | cochlea morphogenesis (GO:0090103) | 3.26425989 |
| 81 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.26414992 |
| 82 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.26259547 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 3.24894373 |
| 84 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.24836628 |
| 85 | adenosine receptor signaling pathway (GO:0001973) | 3.24612959 |
| 86 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24458868 |
| 87 | response to muramyl dipeptide (GO:0032495) | 3.23708001 |
| 88 | regulation of establishment of planar polarity (GO:0090175) | 3.22235798 |
| 89 | proximal/distal pattern formation (GO:0009954) | 3.21477524 |
| 90 | adhesion of symbiont to host (GO:0044406) | 3.20591180 |
| 91 | cranial suture morphogenesis (GO:0060363) | 3.20041393 |
| 92 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.19707020 |
| 93 | axon extension involved in axon guidance (GO:0048846) | 3.19707020 |
| 94 | renal filtration (GO:0097205) | 3.17314893 |
| 95 | prostate gland epithelium morphogenesis (GO:0060740) | 3.16593048 |
| 96 | regulation of cholesterol storage (GO:0010885) | 3.15830335 |
| 97 | lung-associated mesenchyme development (GO:0060484) | 3.14952496 |
| 98 | organ induction (GO:0001759) | 3.12910508 |
| 99 | digestive tract morphogenesis (GO:0048546) | 3.12196111 |
| 100 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.11859666 |
| 101 | non-canonical Wnt signaling pathway (GO:0035567) | 3.10958062 |
| 102 | establishment of monopolar cell polarity (GO:0061162) | 3.10624395 |
| 103 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.10624395 |
| 104 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.09674293 |
| 105 | embryonic hindlimb morphogenesis (GO:0035116) | 3.09624052 |
| 106 | regulation of heart morphogenesis (GO:2000826) | 3.09605408 |
| 107 | mesodermal cell differentiation (GO:0048333) | 3.09476043 |
| 108 | limb bud formation (GO:0060174) | 3.08437498 |
| 109 | regulation of organ formation (GO:0003156) | 3.07734379 |
| 110 | granulocyte activation (GO:0036230) | 3.07472966 |
| 111 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.05239338 |
| 112 | dorsal/ventral axis specification (GO:0009950) | 3.05184794 |
| 113 | barbed-end actin filament capping (GO:0051016) | 3.05157789 |
| 114 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.04085871 |
| 115 | branch elongation of an epithelium (GO:0060602) | 3.04081342 |
| 116 | somite development (GO:0061053) | 3.03952964 |
| 117 | head development (GO:0060322) | 3.03899775 |
| 118 | activation of MAPKKK activity (GO:0000185) | 3.02826265 |
| 119 | anatomical structure regression (GO:0060033) | 3.02312173 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 3.01871463 |
| 121 | establishment of planar polarity (GO:0001736) | 3.01841767 |
| 122 | establishment of tissue polarity (GO:0007164) | 3.01841767 |
| 123 | cellular response to arsenic-containing substance (GO:0071243) | 3.01773634 |
| 124 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.00516222 |
| 125 | glomerular filtration (GO:0003094) | 3.00338270 |
| 126 | cellular response to lipopolysaccharide (GO:0071222) | 2.99866505 |
| 127 | otic vesicle formation (GO:0030916) | 2.99356996 |
| 128 | kidney mesenchyme development (GO:0072074) | 2.97924472 |
| 129 | germinal center formation (GO:0002467) | 2.97743234 |
| 130 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.96774655 |
| 131 | regulation of leukocyte degranulation (GO:0043300) | 2.95483108 |
| 132 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94470136 |
| 133 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.94069985 |
| 134 | negative regulation of embryonic development (GO:0045992) | 2.93008970 |
| 135 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.92520754 |
| 136 | positive regulation by symbiont of host defense response (GO:0052509) | 2.91221784 |
| 137 | modulation by symbiont of host defense response (GO:0052031) | 2.91221784 |
| 138 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.91221784 |
| 139 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.91221784 |
| 140 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.91221784 |
| 141 | modulation by symbiont of host immune response (GO:0052553) | 2.91221784 |
| 142 | lung lobe morphogenesis (GO:0060463) | 2.88797268 |
| 143 | regulation of chondrocyte differentiation (GO:0032330) | 2.88336328 |
| 144 | organ formation (GO:0048645) | 2.87910047 |
| 145 | positive regulation of mast cell activation (GO:0033005) | 2.87715170 |
| 146 | cellular response to molecule of bacterial origin (GO:0071219) | 2.87110655 |
| 147 | diol metabolic process (GO:0034311) | 2.86563711 |
| 148 | glial cell migration (GO:0008347) | 2.85678124 |
| 149 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.85192393 |
| 150 | regulation of cardioblast proliferation (GO:0003264) | 2.85192393 |
| 151 | pinocytosis (GO:0006907) | 2.84459717 |
| 152 | positive regulation of gastrulation (GO:2000543) | 2.83768313 |
| 153 | positive regulation of cholesterol efflux (GO:0010875) | 2.83308525 |
| 154 | regulation of cartilage development (GO:0061035) | 2.82946507 |
| 155 | pharyngeal system development (GO:0060037) | 2.82289171 |
| 156 | regulation of mesenchymal cell proliferation (GO:0010464) | 2.82226483 |
| 157 | regulation of interferon-alpha production (GO:0032647) | 2.81420989 |
| 158 | reactive oxygen species biosynthetic process (GO:1903409) | 2.80948688 |
| 159 | negative regulation of lipid storage (GO:0010888) | 2.80909053 |
| 160 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80162094 |
| 161 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.80058819 |
| 162 | hippo signaling (GO:0035329) | 2.79729844 |
| 163 | heart morphogenesis (GO:0003007) | 2.79199538 |
| 164 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.78276694 |
| 165 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.77855406 |
| 166 | outflow tract septum morphogenesis (GO:0003148) | 2.77500637 |
| 167 | lysosome organization (GO:0007040) | 2.76770095 |
| 168 | lytic vacuole organization (GO:0080171) | 2.76770095 |
| 169 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.76027351 |
| 170 | cell migration involved in heart development (GO:0060973) | 2.74080800 |
| 171 | regulation of morphogenesis of a branching structure (GO:0060688) | 2.72958828 |
| 172 | respiratory tube development (GO:0030323) | 2.72736347 |
| 173 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.72256381 |
| 174 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72187055 |
| 175 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.71926449 |
| 176 | macrophage activation (GO:0042116) | 2.71387299 |
| 177 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.70804035 |
| 178 | embryonic camera-type eye development (GO:0031076) | 2.70123596 |
| 179 | response to protozoan (GO:0001562) | 2.68108023 |
| 180 | vitamin D metabolic process (GO:0042359) | 2.67569062 |
| 181 | mammary gland epithelial cell differentiation (GO:0060644) | 2.66943829 |
| 182 | embryonic limb morphogenesis (GO:0030326) | 2.66780395 |
| 183 | embryonic appendage morphogenesis (GO:0035113) | 2.66780395 |
| 184 | decidualization (GO:0046697) | 2.66710360 |
| 185 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.66349510 |
| 186 | mannose metabolic process (GO:0006013) | 2.66238085 |
| 187 | myeloid cell activation involved in immune response (GO:0002275) | 2.66136968 |
| 188 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.65398069 |
| 189 | positive regulation of interleukin-6 production (GO:0032755) | 2.65159320 |
| 190 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.64618295 |
| 191 | protein localization to endosome (GO:0036010) | 2.64430646 |
| 192 | pattern specification involved in kidney development (GO:0061004) | 2.62966435 |
| 193 | metanephric mesenchyme development (GO:0072075) | 2.62395956 |
| 194 | hair follicle morphogenesis (GO:0031069) | 2.62288185 |
| 195 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.61269652 |
| 196 | negative regulation of osteoblast proliferation (GO:0033689) | 2.60551338 |
| 197 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.59415150 |
| 198 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.59113938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.52083358 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.53383435 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.34005888 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.84880422 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.67769950 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.57955978 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.56974931 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.40437628 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.36882214 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31765018 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98649830 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.94104068 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.77596102 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74865571 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.69036931 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55192978 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55192978 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48765736 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48550050 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47020732 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46243566 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.41536786 |
| 23 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.33595150 |
| 24 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.28830154 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.28204333 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.26914525 |
| 27 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.21337953 |
| 28 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.17719902 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.17406714 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15818158 |
| 31 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.15364535 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13880228 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.12162253 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09507353 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.08378871 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06904340 |
| 37 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.06552559 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.06228354 |
| 39 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.06192380 |
| 40 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 2.01418368 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97688846 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91037658 |
| 43 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.89873100 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.88919270 |
| 45 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.84757246 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81495630 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81283651 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80753000 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79575902 |
| 50 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.79511848 |
| 51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.74569377 |
| 52 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.73053650 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.72136973 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69497285 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69379592 |
| 56 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.67438022 |
| 57 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.67438022 |
| 58 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.67438022 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66255542 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.66238270 |
| 61 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.65633232 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.64061528 |
| 63 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.62959179 |
| 64 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61993823 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57226940 |
| 66 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.55950309 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55137237 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54218933 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53880903 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.53595394 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53434324 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51447166 |
| 73 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.51185325 |
| 74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50548008 |
| 75 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.47348961 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47283054 |
| 77 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.46865358 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45836648 |
| 79 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.45107137 |
| 80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43824104 |
| 81 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43499288 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43406839 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43394288 |
| 84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.43291014 |
| 85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43106702 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43106131 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42079767 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40535953 |
| 89 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.40534414 |
| 90 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.39809480 |
| 91 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.38548524 |
| 92 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37549665 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36513449 |
| 94 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.35547689 |
| 95 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.33999938 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.33129360 |
| 97 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32558543 |
| 98 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.32542693 |
| 99 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32346102 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30802355 |
| 101 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30354529 |
| 102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30247515 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29101408 |
| 104 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.28615423 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26961398 |
| 106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26626204 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25407637 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23816727 |
| 109 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23681967 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23330144 |
| 111 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.21984807 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21948730 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21776235 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21551472 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21435131 |
| 116 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20537833 |
| 117 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20536074 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18853147 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.17866841 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17675003 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17448409 |
| 122 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.17407090 |
| 123 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16775083 |
| 124 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15493430 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15252677 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14174873 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14090633 |
| 128 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14088800 |
| 129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13226580 |
| 130 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13090542 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11687162 |
| 132 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.11156287 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10586320 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09448795 |
| 135 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.09214467 |
| 136 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.08137612 |
| 137 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07316010 |
| 138 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07287383 |
| 139 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07074173 |
| 140 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06904536 |
| 141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06450992 |
| 142 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06044421 |
| 143 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.04190156 |
| 144 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.04070297 |
| 145 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.03648115 |
| 146 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03007301 |
| 147 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02869915 |
| 148 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02738270 |
| 149 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02083670 |
| 150 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01462597 |
| 151 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00877125 |
| 152 | MYC_22102868_ChIP-Seq_BL_Human | 1.00548385 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00175191 |
| 154 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99953671 |
| 155 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99032528 |
| 156 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98730946 |
| 157 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98640217 |
| 158 | MAF_26560356_Chip-Seq_TH1_Human | 0.97800448 |
| 159 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97574962 |
| 160 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.97567154 |
| 161 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96651953 |
| 162 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95442424 |
| 163 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95002785 |
| 164 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94320637 |
| 165 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93914536 |
| 166 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93627574 |
| 167 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92959364 |
| 168 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92919040 |
| 169 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92882566 |
| 170 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92129314 |
| 171 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91959666 |
| 172 | * AR_19668381_ChIP-Seq_PC3_Human | 0.90830919 |
| 173 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89946707 |
| 174 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.89668303 |
| 175 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89569858 |
| 176 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.88647257 |
| 177 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85421360 |
| 178 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83452996 |
| 179 | UTX_26944678_Chip-Seq_JUKART_Human | 0.83236268 |
| 180 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81936664 |
| 181 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81614057 |
| 182 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80838809 |
| 183 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80285369 |
| 184 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.79952563 |
| 185 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79111989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.62735253 |
| 2 | MP0003303_peritoneal_inflammation | 4.96551708 |
| 3 | MP0010030_abnormal_orbit_morphology | 4.64956551 |
| 4 | MP0006082_CNS_inflammation | 3.59875417 |
| 5 | MP0005503_abnormal_tendon_morphology | 3.49747633 |
| 6 | MP0010368_abnormal_lymphatic_system | 3.24927926 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.16747888 |
| 8 | MP0000566_synostosis | 3.10345677 |
| 9 | MP0009840_abnormal_foam_cell | 3.03831459 |
| 10 | MP0004510_myositis | 2.99591144 |
| 11 | MP0003436_decreased_susceptibility_to | 2.93339054 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.90428895 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.87364612 |
| 14 | MP0000537_abnormal_urethra_morphology | 2.84829791 |
| 15 | MP0002938_white_spotting | 2.84218441 |
| 16 | MP0003385_abnormal_body_wall | 2.83954725 |
| 17 | MP0003122_maternal_imprinting | 2.73105539 |
| 18 | MP0000343_altered_response_to | 2.70860892 |
| 19 | MP0004272_abnormal_basement_membrane | 2.70755684 |
| 20 | MP0009785_altered_susceptibility_to | 2.69420348 |
| 21 | MP0009250_abnormal_appendicular_skeleto | 2.62325777 |
| 22 | MP0005248_abnormal_Harderian_gland | 2.57170853 |
| 23 | MP0000604_amyloidosis | 2.50938705 |
| 24 | MP0000762_abnormal_tongue_morphology | 2.50168749 |
| 25 | MP0002419_abnormal_innate_immunity | 2.49323857 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.46991697 |
| 27 | MP0005275_abnormal_skin_tensile | 2.45567434 |
| 28 | MP0008004_abnormal_stomach_pH | 2.45344305 |
| 29 | MP0002254_reproductive_system_inflammat | 2.44224841 |
| 30 | MP0005671_abnormal_response_to | 2.34602255 |
| 31 | MP0003075_altered_response_to | 2.34508885 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 2.33990134 |
| 33 | MP0003724_increased_susceptibility_to | 2.29530554 |
| 34 | MP0001346_abnormal_lacrimal_gland | 2.29231514 |
| 35 | MP0003942_abnormal_urinary_system | 2.20812003 |
| 36 | MP0005000_abnormal_immune_tolerance | 2.17969229 |
| 37 | MP0005187_abnormal_penis_morphology | 2.17103961 |
| 38 | MP0000428_abnormal_craniofacial_morphol | 2.15868296 |
| 39 | MP0003300_gastrointestinal_ulcer | 2.12613701 |
| 40 | MP0000534_abnormal_ureter_morphology | 2.07932405 |
| 41 | MP0001299_abnormal_eye_distance/ | 2.05975534 |
| 42 | MP0000049_abnormal_middle_ear | 2.05727727 |
| 43 | MP0001790_abnormal_immune_system | 2.05476121 |
| 44 | MP0005387_immune_system_phenotype | 2.05476121 |
| 45 | MP0001835_abnormal_antigen_presentation | 2.04203421 |
| 46 | MP0005025_abnormal_response_to | 2.03385801 |
| 47 | MP0003941_abnormal_skin_development | 1.99550610 |
| 48 | MP0009764_decreased_sensitivity_to | 1.99376435 |
| 49 | MP0009053_abnormal_anal_canal | 1.98626877 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.98108708 |
| 51 | MP0002249_abnormal_larynx_morphology | 1.95655888 |
| 52 | MP0003690_abnormal_glial_cell | 1.94467456 |
| 53 | MP0001853_heart_inflammation | 1.94200846 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.91203929 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.90043015 |
| 56 | MP0002282_abnormal_trachea_morphology | 1.85662195 |
| 57 | MP0003755_abnormal_palate_morphology | 1.74816644 |
| 58 | MP0003937_abnormal_limbs/digits/tail_de | 1.73271421 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.71427950 |
| 60 | MP0005508_abnormal_skeleton_morphology | 1.69434668 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.67962097 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.67067590 |
| 63 | MP0002108_abnormal_muscle_morphology | 1.65634147 |
| 64 | MP0003935_abnormal_craniofacial_develop | 1.65273935 |
| 65 | MP0003938_abnormal_ear_development | 1.63327102 |
| 66 | MP0002932_abnormal_joint_morphology | 1.62523971 |
| 67 | MP0001293_anophthalmia | 1.62486252 |
| 68 | MP0002723_abnormal_immune_serum | 1.62070775 |
| 69 | MP0004134_abnormal_chest_morphology | 1.60206513 |
| 70 | MP0003879_abnormal_hair_cell | 1.59397992 |
| 71 | MP0000579_abnormal_nail_morphology | 1.59233187 |
| 72 | MP0003115_abnormal_respiratory_system | 1.57949408 |
| 73 | MP0003329_amyloid_beta_deposits | 1.55460152 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.55254698 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.55254698 |
| 76 | MP0000920_abnormal_myelination | 1.54090967 |
| 77 | MP0002116_abnormal_craniofacial_bone | 1.53675085 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.50467736 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 1.48077130 |
| 80 | MP0001845_abnormal_inflammatory_respons | 1.46124680 |
| 81 | MP0005257_abnormal_intraocular_pressure | 1.44181637 |
| 82 | MP0004947_skin_inflammation | 1.40379103 |
| 83 | MP0005623_abnormal_meninges_morphology | 1.40086524 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 1.39954677 |
| 85 | MP0008469_abnormal_protein_level | 1.39897456 |
| 86 | MP0000462_abnormal_digestive_system | 1.39042400 |
| 87 | MP0000685_abnormal_immune_system | 1.38963102 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 1.38550524 |
| 89 | MP0008789_abnormal_olfactory_epithelium | 1.38211358 |
| 90 | MP0005451_abnormal_body_composition | 1.37725653 |
| 91 | MP0003448_altered_tumor_morphology | 1.34672095 |
| 92 | MP0001501_abnormal_sleep_pattern | 1.34005704 |
| 93 | MP0001800_abnormal_humoral_immune | 1.33739640 |
| 94 | MP0002405_respiratory_system_inflammati | 1.33381311 |
| 95 | MP0005310_abnormal_salivary_gland | 1.33316226 |
| 96 | MP0006054_spinal_hemorrhage | 1.32706331 |
| 97 | MP0003195_calcinosis | 1.32472849 |
| 98 | MP0005367_renal/urinary_system_phenotyp | 1.30492890 |
| 99 | MP0000516_abnormal_urinary_system | 1.30492890 |
| 100 | MP0001819_abnormal_immune_cell | 1.30085088 |
| 101 | MP0002420_abnormal_adaptive_immunity | 1.29588566 |
| 102 | MP0002233_abnormal_nose_morphology | 1.29282646 |
| 103 | MP0003183_abnormal_peptide_metabolism | 1.29098884 |
| 104 | MP0002177_abnormal_outer_ear | 1.29079529 |
| 105 | MP0002102_abnormal_ear_morphology | 1.24924565 |
| 106 | MP0001340_abnormal_eyelid_morphology | 1.21866385 |
| 107 | MP0000647_abnormal_sebaceous_gland | 1.21143082 |
| 108 | MP0002109_abnormal_limb_morphology | 1.21022504 |
| 109 | MP0003634_abnormal_glial_cell | 1.20690674 |
| 110 | MP0004233_abnormal_muscle_weight | 1.20356852 |
| 111 | MP0003119_abnormal_digestive_system | 1.18398954 |
| 112 | MP0003123_paternal_imprinting | 1.18233210 |
| 113 | MP0000163_abnormal_cartilage_morphology | 1.15374228 |
| 114 | MP0000858_altered_metastatic_potential | 1.15218245 |
| 115 | MP0000432_abnormal_head_morphology | 1.13053077 |
| 116 | MP0010155_abnormal_intestine_physiology | 1.11695200 |
| 117 | MP0001958_emphysema | 1.10721840 |
| 118 | MP0000383_abnormal_hair_follicle | 1.09010610 |
| 119 | MP0005166_decreased_susceptibility_to | 1.07733366 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 1.07518579 |
| 121 | MP0003828_pulmonary_edema | 1.05573049 |
| 122 | MP0000733_abnormal_muscle_development | 1.04478388 |
| 123 | MP0002098_abnormal_vibrissa_morphology | 1.03925510 |
| 124 | MP0000613_abnormal_salivary_gland | 1.03619866 |
| 125 | MP0005499_abnormal_olfactory_system | 1.02747520 |
| 126 | MP0005394_taste/olfaction_phenotype | 1.02747520 |
| 127 | MP0005464_abnormal_platelet_physiology | 1.02489629 |
| 128 | MP0001270_distended_abdomen | 1.01515308 |
| 129 | MP0005165_increased_susceptibility_to | 1.00606151 |
| 130 | MP0000751_myopathy | 0.99605538 |
| 131 | MP0001177_atelectasis | 0.98698512 |
| 132 | MP0003121_genomic_imprinting | 0.97618033 |
| 133 | MP0002115_abnormal_skeleton_extremities | 0.95384898 |
| 134 | MP0005390_skeleton_phenotype | 0.94739544 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.93146164 |
| 136 | MP0002751_abnormal_autonomic_nervous | 0.92509085 |
| 137 | MP0002114_abnormal_axial_skeleton | 0.92003761 |
| 138 | MP0002111_abnormal_tail_morphology | 0.91376404 |
| 139 | MP0002697_abnormal_eye_size | 0.91177304 |
| 140 | MP0003279_aneurysm | 0.90744471 |
| 141 | MP0000467_abnormal_esophagus_morphology | 0.89829637 |
| 142 | MP0003806_abnormal_nucleotide_metabolis | 0.89709054 |
| 143 | MP0002060_abnormal_skin_morphology | 0.89654625 |
| 144 | MP0010307_abnormal_tumor_latency | 0.88772537 |
| 145 | MP0002295_abnormal_pulmonary_circulatio | 0.88040111 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.87564291 |
| 147 | MP0002092_abnormal_eye_morphology | 0.87508432 |
| 148 | MP0002132_abnormal_respiratory_system | 0.87496323 |
| 149 | MP0005365_abnormal_bile_salt | 0.86556590 |
| 150 | MP0005391_vision/eye_phenotype | 0.86174961 |
| 151 | MP0001243_abnormal_dermal_layer | 0.85988624 |
| 152 | MP0003136_yellow_coat_color | 0.85985780 |
| 153 | MP0009333_abnormal_splenocyte_physiolog | 0.85501255 |
| 154 | MP0005377_hearing/vestibular/ear_phenot | 0.84760375 |
| 155 | MP0003878_abnormal_ear_physiology | 0.84760375 |
| 156 | MP0003283_abnormal_digestive_organ | 0.84034520 |
| 157 | MP0000716_abnormal_immune_system | 0.82673088 |
| 158 | MP0003656_abnormal_erythrocyte_physiolo | 0.82002952 |
| 159 | MP0001542_abnormal_bone_strength | 0.81878231 |
| 160 | MP0001849_ear_inflammation | 0.81059936 |
| 161 | MP0002925_abnormal_cardiovascular_devel | 0.77586708 |
| 162 | MP0001663_abnormal_digestive_system | 0.77465693 |
| 163 | MP0002896_abnormal_bone_mineralization | 0.77427166 |
| 164 | MP0000778_abnormal_nervous_system | 0.77255763 |
| 165 | MP0005076_abnormal_cell_differentiation | 0.77183394 |
| 166 | MP0005171_absent_coat_pigmentation | 0.76961220 |
| 167 | MP0001286_abnormal_eye_development | 0.76149209 |
| 168 | MP0000631_abnormal_neuroendocrine_gland | 0.75663726 |
| 169 | MP0005253_abnormal_eye_physiology | 0.75520361 |
| 170 | MP0003646_muscle_fatigue | 0.75213746 |
| 171 | MP0003795_abnormal_bone_structure | 0.75069454 |
| 172 | MP0005551_abnormal_eye_electrophysiolog | 0.74998808 |
| 173 | MP0009278_abnormal_bone_marrow | 0.73502717 |
| 174 | MP0005023_abnormal_wound_healing | 0.73357183 |
| 175 | MP0002113_abnormal_skeleton_development | 0.72282499 |
| 176 | MP0009763_increased_sensitivity_to | 0.71801223 |
| 177 | MP0000678_abnormal_parathyroid_gland | 0.71770342 |
| 178 | MP0002234_abnormal_pharynx_morphology | 0.71493823 |
| 179 | MP0002277_abnormal_respiratory_mucosa | 0.71320604 |
| 180 | MP0010678_abnormal_skin_adnexa | 0.69230618 |
| 181 | MP0004742_abnormal_vestibular_system | 0.67908364 |
| 182 | MP0002090_abnormal_vision | 0.67082859 |
| 183 | MP0008260_abnormal_autophagy | 0.64603953 |
| 184 | MP0000681_abnormal_thyroid_gland | 0.64561991 |
| 185 | MP0003186_abnormal_redox_activity | 0.63435596 |
| 186 | MP0005647_abnormal_sex_gland | 0.61947923 |
| 187 | MP0002933_joint_inflammation | 0.61850896 |
| 188 | MP0003633_abnormal_nervous_system | 0.61798902 |
| 189 | MP0003137_abnormal_impulse_conducting | 0.60810068 |
| 190 | MP0008874_decreased_physiological_sensi | 0.59002413 |
| 191 | MP0002429_abnormal_blood_cell | 0.58560820 |
| 192 | MP0003632_abnormal_nervous_system | 0.58307286 |
| 193 | MP0000689_abnormal_spleen_morphology | 0.57670154 |
| 194 | MP0000747_muscle_weakness | 0.57093927 |
| 195 | MP0005164_abnormal_response_to | 0.56667793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.84189980 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.84189980 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 8.84189980 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.67166963 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 6.40076976 |
| 6 | Nuclear cataract (HP:0100018) | 5.84943728 |
| 7 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 5.69555667 |
| 8 | Short 4th metacarpal (HP:0010044) | 5.69555667 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.51831873 |
| 10 | Dysostosis multiplex (HP:0000943) | 5.49099042 |
| 11 | Disinhibition (HP:0000734) | 5.44936307 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.34953944 |
| 13 | Abnormality of the parietal bone (HP:0002696) | 5.23649606 |
| 14 | Loss of speech (HP:0002371) | 5.05135075 |
| 15 | Midline defect of the nose (HP:0004122) | 5.04463002 |
| 16 | Mutism (HP:0002300) | 4.85811300 |
| 17 | Neurofibrillary tangles (HP:0002185) | 4.39187592 |
| 18 | Axonal loss (HP:0003447) | 4.26119837 |
| 19 | Abnormality of the 4th metacarpal (HP:0010012) | 4.24894285 |
| 20 | Broad metatarsal (HP:0001783) | 4.17938696 |
| 21 | Abnormality of macrophages (HP:0004311) | 4.13616389 |
| 22 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.90635941 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.86235148 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.86235148 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.86235148 |
| 26 | Glomerulonephritis (HP:0000099) | 3.84573021 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.83885313 |
| 28 | Shallow orbits (HP:0000586) | 3.82814539 |
| 29 | Trigonocephaly (HP:0000243) | 3.72764341 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.69842100 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.61603047 |
| 32 | Mucopolysacchariduria (HP:0008155) | 3.61603047 |
| 33 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.57921205 |
| 34 | Aplasia of the phalanges of the hand (HP:0009802) | 3.57921205 |
| 35 | Aplasia involving bones of the extremities (HP:0009825) | 3.57921205 |
| 36 | Agnosia (HP:0010524) | 3.57237377 |
| 37 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 3.49483333 |
| 38 | Recurrent abscess formation (HP:0002722) | 3.40141976 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.32352621 |
| 40 | Apathy (HP:0000741) | 3.31606208 |
| 41 | Nasolacrimal duct obstruction (HP:0000579) | 3.31523391 |
| 42 | Neoplasm of the heart (HP:0100544) | 3.29730044 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 3.29616687 |
| 44 | Diminished motivation (HP:0000745) | 3.19493571 |
| 45 | Broad toe (HP:0001837) | 3.12304511 |
| 46 | Inappropriate behavior (HP:0000719) | 3.07089615 |
| 47 | Anteriorly placed anus (HP:0001545) | 3.06503223 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 3.03146119 |
| 49 | Optic neuritis (HP:0100653) | 3.03146119 |
| 50 | Hematochezia (HP:0002573) | 3.02617161 |
| 51 | Orchitis (HP:0100796) | 3.02302290 |
| 52 | Turricephaly (HP:0000262) | 3.01029330 |
| 53 | Abnormality of the nasolacrimal system (HP:0000614) | 3.00014681 |
| 54 | Broad hallux (HP:0010055) | 2.98876797 |
| 55 | Coronal craniosynostosis (HP:0004440) | 2.97846548 |
| 56 | Abnormality of the lacrimal duct (HP:0011481) | 2.95308260 |
| 57 | Alacrima (HP:0000522) | 2.93472949 |
| 58 | Cerebral inclusion bodies (HP:0100314) | 2.93331872 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.90149830 |
| 60 | Retinal atrophy (HP:0001105) | 2.87257142 |
| 61 | Abnormality of the nasal septum (HP:0000419) | 2.86351185 |
| 62 | Complement deficiency (HP:0004431) | 2.86048670 |
| 63 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.81120030 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 2.79500826 |
| 65 | Purpura (HP:0000979) | 2.79162074 |
| 66 | Eczematoid dermatitis (HP:0000976) | 2.77653899 |
| 67 | Down-sloping shoulders (HP:0200021) | 2.75007004 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 2.72891321 |
| 69 | Partial duplication of the phalanx of hand (HP:0009999) | 2.70966111 |
| 70 | Upper motor neuron abnormality (HP:0002127) | 2.70629879 |
| 71 | Follicular hyperkeratosis (HP:0007502) | 2.70529260 |
| 72 | Myositis (HP:0100614) | 2.66349249 |
| 73 | Metaphyseal irregularity (HP:0003025) | 2.64266208 |
| 74 | Short phalanx of the thumb (HP:0009660) | 2.62889589 |
| 75 | Stomatitis (HP:0010280) | 2.61946279 |
| 76 | Milia (HP:0001056) | 2.61623581 |
| 77 | Personality changes (HP:0000751) | 2.61121114 |
| 78 | Abnormal number of incisors (HP:0011064) | 2.58978649 |
| 79 | Synostosis involving the elbow (HP:0003938) | 2.58191487 |
| 80 | Humeroradial synostosis (HP:0003041) | 2.58191487 |
| 81 | Abnormality of the diencephalon (HP:0010662) | 2.56816035 |
| 82 | Increased serum ferritin (HP:0003281) | 2.56397822 |
| 83 | Ankle contracture (HP:0006466) | 2.55142816 |
| 84 | Amyloidosis (HP:0011034) | 2.53528567 |
| 85 | Progressive neurologic deterioration (HP:0002344) | 2.51428344 |
| 86 | Renal duplication (HP:0000075) | 2.50668253 |
| 87 | Mesomelia (HP:0003027) | 2.49575446 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.47303262 |
| 89 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.47066981 |
| 90 | Supernumerary ribs (HP:0005815) | 2.46921412 |
| 91 | Dementia (HP:0000726) | 2.44075956 |
| 92 | Conjunctival telangiectasia (HP:0000524) | 2.34439068 |
| 93 | Peripheral demyelination (HP:0011096) | 2.32103267 |
| 94 | Chorioretinal atrophy (HP:0000533) | 2.30162159 |
| 95 | Cutaneous finger syndactyly (HP:0010554) | 2.29030802 |
| 96 | Type 1 muscle fiber predominance (HP:0003803) | 2.28054169 |
| 97 | Thoracic kyphosis (HP:0002942) | 2.27549934 |
| 98 | Hepatosplenomegaly (HP:0001433) | 2.26516631 |
| 99 | Abnormality of the incisor (HP:0000676) | 2.26069669 |
| 100 | Abnormality of incisor morphology (HP:0011063) | 2.25634278 |
| 101 | Asymmetry of the thorax (HP:0001555) | 2.24778292 |
| 102 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.24405675 |
| 103 | Decreased lacrimation (HP:0000633) | 2.23465304 |
| 104 | Anophthalmia (HP:0000528) | 2.22182146 |
| 105 | Nausea (HP:0002018) | 2.22145002 |
| 106 | Microglossia (HP:0000171) | 2.22090584 |
| 107 | Basal ganglia calcification (HP:0002135) | 2.21495152 |
| 108 | Myocardial infarction (HP:0001658) | 2.19809344 |
| 109 | Concave nail (HP:0001598) | 2.18611726 |
| 110 | Atrophic scars (HP:0001075) | 2.18308113 |
| 111 | Zonular cataract (HP:0010920) | 2.18079311 |
| 112 | Partial duplication of thumb phalanx (HP:0009944) | 2.17238525 |
| 113 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.14853226 |
| 114 | Abnormality of complement system (HP:0005339) | 2.14152674 |
| 115 | Protrusio acetabuli (HP:0003179) | 2.13065677 |
| 116 | Preaxial foot polydactyly (HP:0001841) | 2.12396038 |
| 117 | Deviation of the hallux (HP:0010051) | 2.12231904 |
| 118 | Narrow nasal bridge (HP:0000446) | 2.11595949 |
| 119 | Petechiae (HP:0000967) | 2.09500677 |
| 120 | Pathologic fracture (HP:0002756) | 2.08286325 |
| 121 | Prolonged neonatal jaundice (HP:0006579) | 2.06866834 |
| 122 | Obstructive lung disease (HP:0006536) | 2.06560079 |
| 123 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06560079 |
| 124 | Premature rupture of membranes (HP:0001788) | 2.05503897 |
| 125 | Aplasia cutis congenita (HP:0001057) | 2.05389831 |
| 126 | Hypoplastic labia majora (HP:0000059) | 2.05084725 |
| 127 | Polyneuropathy (HP:0001271) | 2.04997682 |
| 128 | Vitreoretinal degeneration (HP:0000655) | 2.04984667 |
| 129 | Supranuclear gaze palsy (HP:0000605) | 2.04858038 |
| 130 | Abnormality of the 2nd finger (HP:0004100) | 2.04262643 |
| 131 | Progressive visual loss (HP:0000529) | 2.03591431 |
| 132 | Aortic dissection (HP:0002647) | 2.02862317 |
| 133 | Cutaneous syndactyly (HP:0012725) | 2.02827428 |
| 134 | Spontaneous hematomas (HP:0007420) | 2.01711597 |
| 135 | Short hallux (HP:0010109) | 2.01651227 |
| 136 | Abnormality of the middle phalanges of the hand (HP:0009833) | 2.01232166 |
| 137 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.00804488 |
| 138 | Narrow palate (HP:0000189) | 1.99004351 |
| 139 | Aqueductal stenosis (HP:0002410) | 1.98042331 |
| 140 | Keratoconjunctivitis sicca (HP:0001097) | 1.97460354 |
| 141 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95868038 |
| 142 | Cerebral aneurysm (HP:0004944) | 1.95722492 |
| 143 | Cardiomegaly (HP:0001640) | 1.95617778 |
| 144 | Buphthalmos (HP:0000557) | 1.95181962 |
| 145 | Hallux valgus (HP:0001822) | 1.95033914 |
| 146 | Memory impairment (HP:0002354) | 1.94721632 |
| 147 | Bone pain (HP:0002653) | 1.93229665 |
| 148 | Bronchomalacia (HP:0002780) | 1.92461189 |
| 149 | Stomach cancer (HP:0012126) | 1.91923994 |
| 150 | Aplasia/Hypoplasia of metatarsal bones (HP:0001964) | 1.91725941 |
| 151 | Bladder diverticulum (HP:0000015) | 1.90025301 |
| 152 | Pulmonary infiltrates (HP:0002113) | 1.90006426 |
| 153 | Hypoventilation (HP:0002791) | 1.89652941 |
| 154 | Short metatarsal (HP:0010743) | 1.88638850 |
| 155 | Hemoptysis (HP:0002105) | 1.88626505 |
| 156 | Hypoplasia of the maxilla (HP:0000327) | 1.88520899 |
| 157 | Nephritis (HP:0000123) | 1.87705404 |
| 158 | Exostoses (HP:0100777) | 1.86772800 |
| 159 | Recurrent corneal erosions (HP:0000495) | 1.86378739 |
| 160 | Abnormality of iron homeostasis (HP:0011031) | 1.85827065 |
| 161 | Protruding ear (HP:0000411) | 1.85106092 |
| 162 | Bell-shaped thorax (HP:0001591) | 1.84816046 |
| 163 | Abnormality of the lumbar spine (HP:0100712) | 1.84135220 |
| 164 | Abnormality of the labia majora (HP:0012881) | 1.83847191 |
| 165 | Abnormality of lateral ventricle (HP:0030047) | 1.83642189 |
| 166 | Mesangial abnormality (HP:0001966) | 1.81630800 |
| 167 | Bilateral microphthalmos (HP:0007633) | 1.81624340 |
| 168 | Wide anterior fontanel (HP:0000260) | 1.79874454 |
| 169 | Congenital stationary night blindness (HP:0007642) | 1.78588327 |
| 170 | Choanal stenosis (HP:0000452) | 1.76673463 |
| 171 | Broad thumb (HP:0011304) | 1.76098346 |
| 172 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 1.75927611 |
| 173 | Keratoconjunctivitis (HP:0001096) | 1.75409845 |
| 174 | Fragile skin (HP:0001030) | 1.74983629 |
| 175 | Slender build (HP:0001533) | 1.74521753 |
| 176 | Overriding aorta (HP:0002623) | 1.74472299 |
| 177 | Ulnar bowing (HP:0003031) | 1.74131303 |
| 178 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.74029931 |
| 179 | Increased number of teeth (HP:0011069) | 1.73320780 |
| 180 | Overgrowth (HP:0001548) | 1.73251641 |
| 181 | Large earlobe (HP:0009748) | 1.73245824 |
| 182 | Abnormality of the humeroradial joint (HP:0100744) | 1.72816801 |
| 183 | Short middle phalanx of finger (HP:0005819) | 1.71834929 |
| 184 | Vertigo (HP:0002321) | 1.71369924 |
| 185 | Sensorimotor neuropathy (HP:0007141) | 1.70706251 |
| 186 | Sparse lateral eyebrow (HP:0005338) | 1.70231166 |
| 187 | Multiple enchondromatosis (HP:0005701) | 1.68443155 |
| 188 | Aortic aneurysm (HP:0004942) | 1.67327717 |
| 189 | Esophageal varix (HP:0002040) | 1.66771345 |
| 190 | Poor head control (HP:0002421) | 1.64828246 |
| 191 | Abnormality of the basal ganglia (HP:0002134) | 1.62183226 |
| 192 | Vertebral compression fractures (HP:0002953) | 1.62179009 |
| 193 | Acrocyanosis (HP:0001063) | 1.59101730 |
| 194 | Abnormality of the periventricular white matter (HP:0002518) | 1.58216438 |
| 195 | Beaking of vertebral bodies (HP:0004568) | 1.58133240 |
| 196 | Global brain atrophy (HP:0002283) | 1.57545032 |
| 197 | Urinary incontinence (HP:0000020) | 1.56483217 |
| 198 | Recurrent skin infections (HP:0001581) | 1.56183915 |
| 199 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.55490460 |
| 200 | Protuberant abdomen (HP:0001538) | 1.54780527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR2 | 4.48161209 |
| 2 | IRAK3 | 4.39875395 |
| 3 | DDR2 | 4.02793348 |
| 4 | NME2 | 4.02602462 |
| 5 | EPHB2 | 3.84926235 |
| 6 | GRK7 | 3.69661180 |
| 7 | PDGFRA | 3.03178722 |
| 8 | MAP3K14 | 3.02836785 |
| 9 | RIPK1 | 3.01402821 |
| 10 | LATS1 | 2.96323211 |
| 11 | TBK1 | 2.42765268 |
| 12 | BLK | 2.37751482 |
| 13 | ACVR1B | 2.37657761 |
| 14 | DMPK | 2.37161442 |
| 15 | LATS2 | 2.28532545 |
| 16 | MAPK15 | 2.07969708 |
| 17 | SIK1 | 1.95824033 |
| 18 | ICK | 1.90458814 |
| 19 | IKBKB | 1.88604975 |
| 20 | FGFR1 | 1.86840481 |
| 21 | EPHA3 | 1.79675651 |
| 22 | MOS | 1.78177153 |
| 23 | MAP2K6 | 1.75509621 |
| 24 | TIE1 | 1.72135454 |
| 25 | BMX | 1.66477118 |
| 26 | CAMK1G | 1.64999364 |
| 27 | TAOK2 | 1.63026837 |
| 28 | PIM2 | 1.59693976 |
| 29 | IRAK4 | 1.54594617 |
| 30 | TTN | 1.50747451 |
| 31 | FER | 1.46406298 |
| 32 | ADRBK2 | 1.46350774 |
| 33 | CSK | 1.45868862 |
| 34 | RIPK4 | 1.44895205 |
| 35 | PDGFRB | 1.44469569 |
| 36 | TYK2 | 1.44201255 |
| 37 | CSF1R | 1.42512309 |
| 38 | AKT3 | 1.39181567 |
| 39 | IKBKE | 1.37564399 |
| 40 | TGFBR2 | 1.34846741 |
| 41 | CAMK1D | 1.28865504 |
| 42 | ABL2 | 1.28360264 |
| 43 | PTK2 | 1.26345348 |
| 44 | KIT | 1.23673692 |
| 45 | MAP3K10 | 1.22285866 |
| 46 | PAK2 | 1.20577941 |
| 47 | MAP3K13 | 1.11471608 |
| 48 | MAP2K3 | 1.09455939 |
| 49 | PHKG2 | 1.06701152 |
| 50 | PHKG1 | 1.06701152 |
| 51 | ERBB2 | 1.01540542 |
| 52 | TRIB3 | 0.98951064 |
| 53 | CLK1 | 0.98334052 |
| 54 | ERN1 | 0.98311288 |
| 55 | CDK12 | 0.97818402 |
| 56 | TGFBR1 | 0.97616954 |
| 57 | LYN | 0.97508614 |
| 58 | MYLK | 0.97272923 |
| 59 | CHUK | 0.97092369 |
| 60 | WNK1 | 0.96406806 |
| 61 | PDK2 | 0.95992225 |
| 62 | ROCK1 | 0.95502541 |
| 63 | IRAK2 | 0.95124275 |
| 64 | TXK | 0.92777981 |
| 65 | FES | 0.92773685 |
| 66 | CDC42BPA | 0.92450151 |
| 67 | TYRO3 | 0.91675407 |
| 68 | HIPK2 | 0.90531434 |
| 69 | MAP4K1 | 0.88300076 |
| 70 | ZAP70 | 0.85267067 |
| 71 | JAK3 | 0.85153968 |
| 72 | ERBB3 | 0.83908420 |
| 73 | MTOR | 0.83562649 |
| 74 | KSR1 | 0.81088684 |
| 75 | ARAF | 0.80891456 |
| 76 | CAMK4 | 0.77309642 |
| 77 | PRKD2 | 0.75794327 |
| 78 | PTK6 | 0.75753013 |
| 79 | GSK3A | 0.74537752 |
| 80 | MAP3K1 | 0.74494254 |
| 81 | PRPF4B | 0.74150620 |
| 82 | CDK6 | 0.73630951 |
| 83 | PAK3 | 0.73444993 |
| 84 | MAP3K6 | 0.73433968 |
| 85 | UHMK1 | 0.71233560 |
| 86 | BMPR2 | 0.71085835 |
| 87 | TESK2 | 0.70879297 |
| 88 | SYK | 0.70445550 |
| 89 | NTRK2 | 0.67015762 |
| 90 | MAP3K5 | 0.66912711 |
| 91 | ADRBK1 | 0.66570720 |
| 92 | MARK3 | 0.65409746 |
| 93 | PAK6 | 0.65349771 |
| 94 | MAP3K7 | 0.63602219 |
| 95 | MAP2K2 | 0.63245790 |
| 96 | SGK3 | 0.62836155 |
| 97 | STK3 | 0.61997960 |
| 98 | PTK2B | 0.61806285 |
| 99 | PRKD1 | 0.61681615 |
| 100 | PKN1 | 0.61168604 |
| 101 | MARK2 | 0.59863863 |
| 102 | CAMKK2 | 0.59550823 |
| 103 | GRK1 | 0.59238101 |
| 104 | NLK | 0.58097604 |
| 105 | DYRK1B | 0.57817943 |
| 106 | TAOK1 | 0.57565948 |
| 107 | MAPK1 | 0.56974824 |
| 108 | ERBB4 | 0.56619975 |
| 109 | RPS6KC1 | 0.56357654 |
| 110 | RPS6KL1 | 0.56357654 |
| 111 | ZAK | 0.56063918 |
| 112 | PRKCH | 0.55791915 |
| 113 | MET | 0.55595279 |
| 114 | STK10 | 0.55107638 |
| 115 | ROCK2 | 0.54703052 |
| 116 | CDK4 | 0.54641890 |
| 117 | RPS6KA2 | 0.54337227 |
| 118 | MAPK4 | 0.54113771 |
| 119 | LCK | 0.53741226 |
| 120 | LMTK2 | 0.53668829 |
| 121 | NTRK1 | 0.51267221 |
| 122 | DAPK2 | 0.49196824 |
| 123 | STK38 | 0.48855900 |
| 124 | PRKCE | 0.48702626 |
| 125 | LRRK2 | 0.46918668 |
| 126 | JAK1 | 0.45771882 |
| 127 | JAK2 | 0.45060197 |
| 128 | SGK2 | 0.44673363 |
| 129 | MAPK7 | 0.42927346 |
| 130 | BCKDK | 0.42814839 |
| 131 | PIK3CA | 0.42228121 |
| 132 | CAMK1 | 0.40305744 |
| 133 | PDPK1 | 0.39408596 |
| 134 | CDK7 | 0.39055100 |
| 135 | MAP3K3 | 0.38828756 |
| 136 | PIM1 | 0.38747015 |
| 137 | CSNK1A1L | 0.38388576 |
| 138 | SRC | 0.38344900 |
| 139 | DYRK3 | 0.38119179 |
| 140 | BRD4 | 0.37730413 |
| 141 | MAPK3 | 0.36747853 |
| 142 | HCK | 0.36119013 |
| 143 | NEK9 | 0.35904088 |
| 144 | PAK4 | 0.35672375 |
| 145 | MAPK8 | 0.35653578 |
| 146 | MAPK10 | 0.35646597 |
| 147 | RPS6KA6 | 0.35610449 |
| 148 | MAP3K11 | 0.35533813 |
| 149 | INSR | 0.34653482 |
| 150 | RPS6KA1 | 0.34218425 |
| 151 | SGK223 | 0.34168716 |
| 152 | SGK494 | 0.34168716 |
| 153 | MATK | 0.34138981 |
| 154 | MAPK14 | 0.33518138 |
| 155 | FGR | 0.31862106 |
| 156 | CDK3 | 0.31554139 |
| 157 | MAPK12 | 0.30473633 |
| 158 | TESK1 | 0.29789622 |
| 159 | MAP3K8 | 0.28979429 |
| 160 | ABL1 | 0.28819533 |
| 161 | IRAK1 | 0.27349797 |
| 162 | DAPK3 | 0.27338456 |
| 163 | BRAF | 0.27109404 |
| 164 | SIK3 | 0.26716935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 5.10990609 |
| 2 | Basal cell carcinoma_Homo sapiens_hsa05217 | 4.28507354 |
| 3 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 3.91693420 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.90351121 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.09573064 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80327602 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.77210164 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.70672509 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.56585424 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.54883336 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.51794628 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.51185380 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.33299016 |
| 14 | Hippo signaling pathway_Homo sapiens_hsa04390 | 2.33151577 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.32430846 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25326922 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 2.08360135 |
| 18 | Wnt signaling pathway_Homo sapiens_hsa04310 | 2.06652263 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 2.02635659 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.00029112 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97633058 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.96061519 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.94117711 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.90378860 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89793736 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.86259460 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80250556 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.80227890 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.77069213 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.74454598 |
| 31 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.73617812 |
| 32 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.73214624 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.70395604 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.67209285 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.66842847 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.64903269 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.61771818 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61505708 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60933283 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60751876 |
| 41 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.59762107 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.58210246 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57878593 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52922132 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.50164041 |
| 46 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.49737912 |
| 47 | Pathways in cancer_Homo sapiens_hsa05200 | 1.48971283 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 1.47103965 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.44224128 |
| 50 | Melanoma_Homo sapiens_hsa05218 | 1.41626925 |
| 51 | Prostate cancer_Homo sapiens_hsa05215 | 1.39881522 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.36616429 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 1.36419828 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.35392528 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 1.32570765 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32254744 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30633558 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28648743 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26804155 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25200796 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 1.24272087 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21154166 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20262072 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19844005 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 1.14602305 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.12425622 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12333550 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.12321141 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 1.11049041 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 1.10697118 |
| 71 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.09980840 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09125996 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 1.08957738 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 1.08178007 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06512533 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05428278 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.04684884 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01716658 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99677665 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97076796 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96608266 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96077489 |
| 83 | Tight junction_Homo sapiens_hsa04530 | 0.96011228 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95743797 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95611425 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95538252 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94826206 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91962873 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90842268 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89401090 |
| 91 | GABAergic synapse_Homo sapiens_hsa04727 | 0.89369152 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89028334 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.88824747 |
| 94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88155445 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.87853928 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87649975 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87079232 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86120082 |
| 99 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.85044781 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84721380 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84427229 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83531103 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82091786 |
| 104 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81767169 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81373808 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80543239 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.79334063 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78636034 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78139240 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77402537 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.77099621 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.77063271 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74255724 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.73222133 |
| 115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.72850562 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72693947 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72636083 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72312592 |
| 119 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72271361 |
| 120 | Long-term depression_Homo sapiens_hsa04730 | 0.71195191 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70826034 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70219454 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68891520 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.67230498 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67026979 |
| 126 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66361943 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66073156 |
| 128 | Insulin secretion_Homo sapiens_hsa04911 | 0.65413750 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65410869 |
| 130 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64457710 |
| 131 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63716440 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63191014 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63159288 |
| 134 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63125582 |
| 135 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62691396 |
| 136 | Hepatitis B_Homo sapiens_hsa05161 | 0.61726854 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61184736 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61103864 |
| 139 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60841121 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59610228 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59426557 |
| 142 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59339377 |
| 143 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58867553 |
| 144 | Shigellosis_Homo sapiens_hsa05131 | 0.58409955 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57923086 |
| 146 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57868930 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57060009 |
| 148 | Platelet activation_Homo sapiens_hsa04611 | 0.56653510 |
| 149 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55782799 |
| 150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54875158 |
| 151 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54234871 |
| 152 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52897234 |
| 153 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52340543 |
| 154 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51248939 |
| 155 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51222306 |
| 156 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51025749 |
| 157 | Measles_Homo sapiens_hsa05162 | 0.47500126 |
| 158 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47197433 |
| 159 | Mineral absorption_Homo sapiens_hsa04978 | 0.46429490 |
| 160 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46292164 |
| 161 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44917021 |
| 162 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43804315 |
| 163 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43095533 |
| 164 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42823701 |
| 165 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40331352 |
| 166 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40027554 |
| 167 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39955998 |
| 168 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.38726833 |
| 169 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37617031 |
| 170 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35545976 |
| 171 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33878235 |
| 172 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33828406 |
| 173 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33328477 |
| 174 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29995528 |
| 175 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22386615 |
| 176 | Endocytosis_Homo sapiens_hsa04144 | 0.19145536 |
| 177 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10795888 |

